Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Successful completion of phase I/II clinical trial of VIMRxyn in brain cancer

Oct. 30, 1998

Camptothecin analogues and prodrugs described in patent literature by SCRAS

Oct. 30, 1998

Vitamin D analogue Ro-25-9716 potentially useful in treating myeloid leukemia

Oct. 30, 1998

Novel class of microtubule-destabilizing agents synthesized and evaluated at Kansas State

Oct. 29, 1998

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Human trials of new liposomal ether lipid approved by FDA

Oct. 28, 1998

Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC

Oct. 28, 1998

Genetronics targets prostate cancer as a new indication for electroporation therapy

Oct. 28, 1998

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Temodal recommended for approval in E.U.

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...